Chordia Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is September - August.

Millions JPY. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Feb '26 Feb 28, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023
Cash & Equivalents	2,448	2,549	4,330	4,799
Cash & Short-Term Investments	2,448	2,549	4,330	4,799
Cash Growth	-25.28%	-41.13%	-9.78%	-
Prepaid Expenses	23.3	24.9	38.16	52.06
Other Current Assets	28.95	95.18	237.64	40.52
Total Current Assets	2,500	2,669	4,605	4,892
Property, Plant & Equipment	-	-	2.75	4.43
Other Intangible Assets	-	-	0.62	2.5
Other Long-Term Assets	12.26	12.32	23.59	10.59
Total Assets	2,512	2,681	4,632	4,909
Accounts Payable	132.04	120.01	382.43	248.43
Accrued Expenses	-	29.33	2.3	25.6
Current Income Taxes Payable	7.72	90.5	54.29	2.42
Other Current Liabilities	57.49	4.5	32.06	131.79
Total Current Liabilities	197.24	244.34	471.07	408.24
Other Long-Term Liabilities	0	0	0	-
Total Liabilities	197.24	244.34	471.07	408.24
Common Stock	1,129	876.27	845.27	90
Additional Paid-In Capital	1,811	9,066	9,035	8,280
Retained Earnings	-633.7	-7,508	-5,722	-3,895
Comprehensive Income & Other	9.66	2.52	2.94	25.93
Shareholders' Equity	2,315	2,437	4,161	4,501
Total Liabilities & Equity	2,512	2,681	4,632	4,909
Net Cash (Debt)	2,448	2,549	4,330	4,799
Net Cash Growth	-25.28%	-41.13%	-9.78%	-
Net Cash Per Share	35.01	37.15	73.72	85.02
Filing Date Shares Outstanding	73.73	68.99	67.68	56.44
Total Common Shares Outstanding	73.73	68.99	67.68	56.44
Working Capital	2,303	2,425	4,134	4,483
Book Value Per Share	31.40	35.32	61.49	79.74
Tangible Book Value	2,315	2,437	4,161	4,498
Tangible Book Value Per Share	31.40	35.32	61.48	79.70
Machinery	10.48	10.48	11.21	10.68

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.